Lucio N. Gordan on Muck Rack

Lucio N. Gordan

United States
As seen in: Community Oncology Alliance, Wiley Online Library, MDPI, Taylor & Francis Online, Fort Myers News-Press, Healio, The Center Square, American Journal of Managed Care, ONCOLOGY journal, OncLive, Targeted Oncology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lucio N.

Contact Lucio N., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States

|
By Lucio N. Gordan, Fan Mu, Nina H. Kim, Arielle G. Bensimon
| Taylor & Francis Online
ABSTRACT Aims Teclistamab and elranatamab are bispecific antibodies recently approved for the treatment of triple class-exposed relapsed/refractory multiple myeloma (RRMM). This study assessed the relative efficacy and economic value of teclistamab and elranatamab through a matching-adjusted indirect comparison (MAIC) and cost per responder analysis using data from the MajesTEC-1 (NCT03145181/NCT04557098) and MagnetisMM-3 (NCT04649359) trials.
Open in Who Shared Issue with article?

Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta‐Analysis

|
By Lucio N. Gordan, Rohan Medhekar, Alex Z. Fu, Mostafa Shokoohi
| Wiley Online Library Verified
1 Introduction Multiple myeloma (MM) makes up 1.8% of all cancer diagnosis in the US, with an incidence rate of 7.0 per 100,000 individuals [1]. MM is a multifactorial disease with risk factors such as male sex, increased age, prior family history, pernicious anemia, genetic factors, and occupational factors [2].
Open in Who Shared Issue with article?

Op-Ed: Community oncologists need policymaker support to stay independent

|
By Lucio N. Gordan
| The Black Chronicle
Nearly every American’s life has been touched by cancer in some way. The American Cancer Society estimates more than 2 million people will be diagnosed with cancer in 2025, with over 171,000 of those cases in Florida. As an oncologist to the Florida community, I have seen that access to treatment, cost of care, and being close to supportive family and friends are critical factors in a patient’s fight against cancer. Community oncologists are focused on building trust with patients.
Open in Who Shared View Duplicates (3) Issue with article?
See all 14 licensed articles (47 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified